Skip to main content

Advertisement

Log in

Seroma in breast surgery: all the surgeons fault?

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Background

Despite a trend for less radical surgical approaches in breast cancer due to better understanding of tumour biology and new treatment options such as neoadjuvant chemotherapy (NAC) and intra-operative radiotherapy (IORT), seroma production remains one of the main surgical side effects that can result in prolonged recovery, delay of radiotherapy and patient discomfort. The aim of this study is to provide an update on risk factors for seroma production after breast cancer surgery considering the latest treatment options.

Methods

A retrospective analysis of seroma production in primary breast cancer patients treated between 01.01.2010 and 31.12.2014 at the Breast Cancer Centre, University Hospital Ulm, was performed. Patients with previous breast/axillary surgery or more than one intervention were excluded. Seroma formation was measured using wound drains placed in breast and axilla.

Results

In total, 581 patients met the inclusion criteria. Median age at diagnosis was 60 years, and median BMI 25.6 kg/m2. 60 (10.3%) patients had a mastectomy, 175 (30.1%) patients received IORT, and 72 (12.4%) patients received NAC. Median amount of seroma production was 82.5 ml (range 0–3012.5 ml). Multivariate analysis revealed that most of the observed variation in seroma production was due to type of surgery (mastectomy vs. breast conserving), length of surgery and number of removed lymph nodes. Both NAC and IORT explained a significant but very small amount of the observed variation in seroma production.

Conclusion

The most important factors for seroma production are extent and duration of breast surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Veronesi U, Luini A, Galimberti V, Zurrida S (1991) Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18(1):70–75

    Article  Google Scholar 

  2. Abt NB, Flores JM, Baltodano PA, Sarhane KA, Abreu FM, Cooney CM et al (2014) Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction. JAMA Surg 149(10):1068–1076

    Article  PubMed Central  PubMed  Google Scholar 

  3. Sedlmayer F, Sautter-Bihl M-L, Budach W, Dunst J, Fastner G, Feyer P et al (2013) DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189(10):825–833

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Boostrom SY, Throckmorton AD, Boughey JC, Holifield AC, Zakaria S, Hoskin TL et al (2009) Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg 208(1):148–150

    Article  PubMed  Google Scholar 

  5. Silverstein MJ, Fastner G, Maluta S, Reitsamer R, Goer DA, Vicini F et al (2014) Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2–TARGIT. Ann Surg Oncol 21(12):3793–3799

    Article  PubMed Central  PubMed  Google Scholar 

  6. Buchholz TA, Somerfield MR, Griggs JJ, El-Eid S, Hammond MEH, Lyman GH et al (2014) Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. J Clin Oncol 32(14):1502–1506

    Article  PubMed  Google Scholar 

  7. Kreienberg R, Kopp I, Albert U-S, Bartsch HH, Beckmann MW, Berg D et al (2012) Interdisziplinäre S3-Leitlinie und Nachsorge des Leitlinie. Ger Cancer Soc 2012(7):32–45

    Google Scholar 

  8. Srivastava V, Basu S, Shukla VK (2012) Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer 15(4):373–380

    Article  PubMed Central  PubMed  Google Scholar 

  9. Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S et al (2006) Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol 36(4):197–206

    Article  PubMed  Google Scholar 

  10. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23(19):4312–4321

    Article  PubMed  Google Scholar 

  11. Ebner FK, Friedl TWP, Reich A, Janni W, Rempen A, Degregorio N et al (2013) Does non-placement of a drain in breast surgery increase the rate of complications and revisions? Geburtshilfe Frauenheilkd 73(11):1128–1134

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Garbay J-R, Thoury A, Moinon E, Cavalcanti A, Di Palma M, Karsenti G et al (2012) Axillary padding without drainage after axillary lymphadenectomy—a prospective study of 299 patients with early breast cancer. Breast Care (Basel) 7(3):231–235

    Article  Google Scholar 

  13. Taylor JC, Rai S, Hoar F, Brown H, Vishwanath L (2013) Breast cancer surgery without suction drainage: the impact of adopting a “no drains” policy on symptomatic seroma formation rates. Eur J Surg Oncol 39:334–338

    Article  CAS  PubMed  Google Scholar 

  14. Thomson DR, Sadideen H, Furniss D (2013) Drainage tube placement after lymph gland removal from the armpit for breast cancer. Wiley, New York

    Google Scholar 

  15. Glechner A, Wöckel A, Gartlehner G, Thaler K, Strobelberger M, Griebler U et al (2013) Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. Eur J Cancer 49:812–825

    Article  PubMed  Google Scholar 

  16. Joyce DP, Manning A, Carter M, Hill ADK, Kell MR, Barry M (2015) Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer. Breast Cancer Res Treat 153:235–240

    Article  CAS  PubMed  Google Scholar 

  17. Shah-Khan M, Boughey JC (2012) Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial. Cancer Control 19(4):267–276

    Article  PubMed  Google Scholar 

  18. Janni W, Kühn T, Schwentner L, Kreienberg R, Fehm T, Wöckel A (2014) Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits. Dtsch Arztebl Int 111(14):244–249

    PubMed  PubMed Central  Google Scholar 

  19. Ebner F, Wöckel A, Janni W, Kreienberg R, Schwentner L, Wischnewsky M (2017) Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival. J Cancer Res Clin Oncol 143:1823–1831

    Article  PubMed  Google Scholar 

  20. Balakrishnan A, Ravichandran D (2011) Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy. Br J Cancer 105(12):1825–1829

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Hille U, Soergel P, Länger F, Schippert C, Makowski L, Hillemanns P (2002) Aromatase inhibitors as solely treatment in postmenopausal breast cancer patients. Breast J 18(2):145–150

    Article  Google Scholar 

  22. Hind D, Wyld L, Reed MW (2007) Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 96(7):1025–1029

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Headon H, Wazir U, Kasem A, Mokbel K (2016) Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: a systematic review and meta-analysis. Mol Clin Oncol 4(5):863–867

    Article  PubMed Central  PubMed  Google Scholar 

  24. Cortadellas T, Córdoba O, Espinosa-Bravo M, Mendoza-Santin C, Rodríguez-Fernández J, Esgueva A et al (2011) Electrothermal bipolar vessel sealing system in axillary dissection: a prospective randomized clinical study. Int J Surg 9(8):636–640

    Article  PubMed  Google Scholar 

  25. Manouras A, Markogiannakis H, Genetzakis M, Filippakis GM, Lagoudianakis EE, Kafiri G et al (2008) Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg. 143(6):575–580 (discussion 581)

    Article  PubMed  Google Scholar 

  26. Nespoli L, Antolini L, Stucchi C, Nespoli A, Valsecchi MG, Gianotti L (2012) Axillary lymphadenectomy for breast cancer. A randomized controlled trial comparing a bipolar vessel sealing system to the conventional technique. Breast 21(6):739–745

    Article  PubMed  Google Scholar 

  27. Canavese G, Catturich A, Vecchio C, Gipponi M, Tomei D, Sertoli MR et al (1997) Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol 23(1):10–12

    Article  CAS  PubMed  Google Scholar 

  28. Kraus-Tiefenbacher U, Welzel G, Brade J, Hermann B, Siebenlist K, Wasser KS et al (2010) Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery. Int J Radiat Oncol Biol Phys 77(4):1140–1145

    Article  PubMed  Google Scholar 

  29. Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S et al (2013) Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy X-rays. Radiat Oncol 8:95

    Article  PubMed Central  PubMed  Google Scholar 

  30. Ebner F, Schramm A, Bottke D, Friedl TW, Wiegel T, Fink V et al (2016) Comparison of seroma production in breast conserving surgery with or without intraoperative radiotherapy as tumour bed boost. Arch Gynecol Obstet 294:861–866

    Article  CAS  PubMed  Google Scholar 

  31. Cracco S, Semprini G, Cattin F, Gregoraci G, Zeppieri M, Isola M et al (2015) Impact of intraoperative radiotherapy on cosmetic outcome and complications after oncoplastic breast surgery. Breast J 21(3):285–290

    Article  PubMed  Google Scholar 

Download references

Funding

No external or additional funding was used for this study.

Author information

Authors and Affiliations

Authors

Contributions

FE: conceptualization, writing original draft, review and editing. TWPF: data curation, formal analysis. AG: resources. KL: supporting. IB: validation. WJ: supervision. NG: conceptualization, review and editing.

Corresponding author

Correspondence to Nikolaus de Gregorio.

Ethics declarations

Conflict of interest

All authors declare that they have no potential conflict of interest.

Ethical approval

This study was approved by the local ethic committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ebner, F., Friedl, T.W.P., de Gregorio, A. et al. Seroma in breast surgery: all the surgeons fault?. Arch Gynecol Obstet 298, 951–959 (2018). https://doi.org/10.1007/s00404-018-4880-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-018-4880-8

Keywords

Navigation